Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202303061 A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2) Lung Cancer SHH Pulmonary Medicine Kang-Yun Lee Rong-Wei Jhou
0963969166
N202312002 A Randomized, Double-Blind, Placebo-Controlled, Multi-Regional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy Lung Cancer SHH Pulmonary Medicine Kang-Yun Lee Rong-Wei Jhou
0963969166
N201910049 A Phase I, Open label, dose escalation study to Evaluate The Safety and Tolerability after intravenous infusion of UMC119-06 in subjects with moderate chronic obstructive pulmonary disease (COPD) chronic obstructive pulmonary disease (COPD) SHH Pulmonary Medicine Kang-Yun Lee Rong-Wei Jhou
0963969167
N202012035 Development of stem cell culture technology in vitro - Hair follicle and skin sample collection Dermatosis/skin disease SHH Dermatology Woan-Ruoh Lee Lu-Fan Lai
0970747584 #2388
N202102073 Prospective Observational Cohort Study of Patients with Moderate to Severe Chronic Plaque Psoriasis in Taiwan Chronic Plaque Psoriasis SHH Dermatology Woan-Ruoh Lee Lu-Fan Lai
0970747584 #2389
N202307012 An Open-Label multinational, multicenter study to evaluate the long-term safety, tolerability and efficacy of subcutaneous amlitelimab in adult participants with moderate to severe atopic dermatitis Atopic Dermatitis SHH Dermatology Woan-Ruoh Lee Ya-Chun Chang
0976909019
N202212018 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis Myasthenia Gravis SHH Neurology Hou-Chang Chiu Yi-Ping Ji
0958790027
N202212013 A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Anifrolumab in Asian Participants with Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus SHH Allergy, Immunology and Rheumatology Yu-Sheng Chang Ci-Han Chen
0911913137
N202110016 A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis Proliferative Lupus Nephritis SHH Allergy, Immunology and Rheumatology Yu-Sheng Chang Ci-Han Chen
0911913138
N202203156 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy Nephropathy SHH Nephrology Yung-Ho Hsu Yun-Hui Wang
0972223815
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP